Try

Moderna, Inc.

MRNAUnited States

55 filed reports · 476 financial concepts · 2 earnings calls · 32 media appearances

Filed reports

55 reports · Dec 2018 to Jun 2026

Each report counts once it has at least one extracted financial fact. Also extracted from these reports: 90 guidance figures.

Report typeReportsFactsPeriods
Current · 8-KSEC EDGAR2490Mar 2021 to Jun 2026
Quarterly · 10-QSEC EDGAR235,081Mar 2019 to Jun 2026
Annual · 10-KSEC EDGAR84,422Dec 2018 to Dec 2025

Documents

PeriodTypePeriod endPublishedFactsSource
FY2026 Q210-QJun 30, 2026Jul 31, 2026502Open
FY2026 Q28-KJun 30, 2026Jul 31, 20263Open
FY2026 Q18-KMar 31, 2026May 1, 20263Open
FY2026 Q110-QMar 31, 2026May 1, 2026287Open
FY202510-KDec 31, 2025Feb 20, 20261,038Open
FY2025 Q48-KDec 31, 2025Feb 13, 20263Open
FY2025 Q48-KDec 31, 2025Jan 12, 20261Open
FY2025 Q38-KSep 30, 2025Nov 6, 20254Open
FY2025 Q310-QSep 30, 2025Nov 6, 2025300Open
FY2025 Q210-QJun 30, 2025Aug 1, 2025210Open
FY2025 Q28-KJun 30, 2025Aug 1, 20254Open
FY2025 Q110-QMar 31, 2025May 1, 2025204Open

Financial data

476 concepts · 9,593 facts

Each concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.

Financial459 concepts · 8,901 facts · Dec 2015 to Jul 2026

  • Total68 · Dec 2019 to Jun 2026
  • Cash and cash equivalents at carrying value48 · Dec 2015 to Jun 2026
  • Operating income loss48 · Dec 2016 to Jun 2026
  • Revenue48 · Dec 2016 to Jun 2026
  • Stockholders equity (US GAAP)48 · Dec 2015 to Jun 2026
  • Cash cash equivalents restricted cash and restricted cash equivalents46 · Dec 2016 to Jun 2026
  • Other external goods and services45 · Dec 2017 to Jun 2026
  • Adjustments to additional paid in capital sharebased compensation requisite service period recognition value44 · Dec 2016 to Jun 2026
  • Allocated share based compensation expense44 · Dec 2016 to Jun 2026
  • Capital expenditures incurred but not yet paid44 · Dec 2016 to Jun 2026
  • Comprehensive income net of tax44 · Dec 2016 to Jun 2026
  • Depreciation depletion and amortization44 · Dec 2016 to Jun 2026
  • General and administrative expense (US GAAP)44 · Dec 2016 to Jun 2026
  • Income tax expense benefit44 · Dec 2016 to Jun 2026
  • Increase decrease in accounts payable44 · Dec 2016 to Jun 2026
  • Increase decrease in accounts receivable44 · Dec 2016 to Jun 2026
  • Increase decrease in accrued liabilities44 · Dec 2016 to Jun 2026
  • Increase decrease in other operating liabilities44 · Dec 2016 to Jun 2026
  • Increase decrease in prepaid deferred expense and other assets44 · Dec 2016 to Jun 2026
  • Investment income interest44 · Dec 2016 to Jun 2026
  • Investment income net amortization of discount and premium44 · Dec 2016 to Jun 2026
  • Net cash provided by used in financing activities44 · Dec 2016 to Jun 2026
  • Net cash provided by used in investing activities44 · Dec 2016 to Jun 2026
  • Net cash provided by used in operating activities44 · Dec 2016 to Jun 2026

Product12 concepts · 577 facts · Dec 2016 to Jun 2026

  • Revenue334 · Dec 2016 to Jun 2026
  • Contract with customer liability cumulative catch up adjustment to revenue change in measure of progress90 · Dec 2020 to Jun 2026
  • Net product sales90 · Dec 2020 to Jun 2026
  • Revenue (excluding assessed tax)22 · Mar 2018 to Dec 2020
  • Collaboration Revenue by Strategic Collaborator:10 · Mar 2021 to Dec 2022
  • Number of commercial products10 · Sep 2024 to Jun 2026
  • Contract with customer asset purchase8 · Sep 2021 to Dec 2022
  • Contract with customer liability change in timeframe performance obligation satisfied revenue recognized4 · Jun 2020 to Dec 2020
  • Contract with customer liability revenue recognized4 · Jun 2020 to Dec 2020
  • Cost of goods and services sold (US GAAP)3 · Dec 2020 to Dec 2022
  • Collaboration Revenue by Strategic Collaborator1 · Dec 2020
  • Contract with customer asset cumulative catch up adjustment to revenue change in measure of progress1 · Mar 2021

Guidance4 concepts · 90 facts · May 2021 to Jul 2026

  • Capital Expenditures Guidance42 · May 2021 to Jul 2026
  • Revenue Guidance40 · May 2021 to Nov 2025
  • Effective Tax Rate Guidance4 · Aug 2021 to May 2022
  • Revenue Growth Guidance4 · Jan 2026 to Jul 2026

Geography1 concepts · 25 facts · Dec 2018 to Dec 2025

  • Revenue25 · Dec 2018 to Dec 2025

Segments

602 facts

Figures broken down by business line, region, product or another axis the company reports on.

Product or service19 members · 577 facts

  • Product Sales190 · Dec 2018 to Jun 2026
  • Grant84 · Dec 2016 to Jun 2026
  • Collaboration Arrangement Including Arrangements With Affiliate81 · Sep 2019 to Jun 2026
  • Collaboration Arrangement69 · Dec 2016 to Dec 2024
  • Product And Service Other37 · Dec 2021 to Jun 2026
  • License And Royalty22 · Dec 2022 to Jun 2026
  • COVID1916 · Dec 2022 to Jun 2026
  • RSV16 · Dec 2022 to Jun 2026
  • Collaborative Arrangement With Affiliate12 · Dec 2016 to Dec 2019
  • Collaboration arrangement11 · Mar 2018 to Dec 2020
  • Collaboration Arrangement Including Arrangements With Affiliate Member7 · Mar 2019 to Jun 2020
  • Grant7 · Mar 2018 to Mar 2020
  • Other Revenue6 · Mar 2024 to Sep 2025
  • Collaborative Arrangement With Related Party5 · Dec 2017 to Mar 2020
  • Stand Ready Manufacturing4 · Mar 2025 to Jun 2026
  • Collaboration arrangement including arrangements with affiliate member3 · Mar 2018 to Sep 2018
  • Product Sales Distribution Fees3 · Dec 2020 to Dec 2022
  • Stand Ready Manufacturing Revenue3 · Dec 2023 to Dec 2025
  • Collaboration arrangement including arrangements with affiliate1 · Dec 2018

Statement geographical4 members · 25 facts

  • US8 · Dec 2018 to Dec 2025
  • Europe7 · Dec 2019 to Dec 2025
  • Rest Of World7 · Dec 2019 to Dec 2025
  • Non Us3 · Dec 2018 to Dec 2020

Text from filings

Management commentary and risk factors, extracted from SEC filings only.

  • Earnings-release commentary166 claims from 10 reports · Sep 2024 to Jun 2026
  • Management discussion (MD&A) commentary159 claims from 8 reports · Sep 2024 to Jun 2026
  • Risk-factor changes23 claims from 1 reports · Dec 2025
  • Risk factors159 risks from 2 annual reports · 2024 to 2025

Earnings calls

2 calls · May 2026 to Jul 2026

Transcripts with management claims and analyst questions, one per fiscal period.

  • FY2026 Q2Jul 31, 2026
  • FY2026 Q1May 1, 2026

Executive media

32 appearances

Podcasts, interviews and conference appearances by the company's executives, with their claims.

  • TV interviews18 · Jul 2020 to Aug 2026
  • Other appearances12 · Jun 2020 to Jun 2026
  • Conference talks2 · Oct 2020 to Nov 2022

Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Oct 16, 2026) and refreshed every few hours.

Moderna, Inc. (MRNA) data · FactIQ